DK0542255T3 - Monoklont antistof, der genkender C-terminus i hBNP - Google Patents

Monoklont antistof, der genkender C-terminus i hBNP

Info

Publication number
DK0542255T3
DK0542255T3 DK92119353T DK92119353T DK0542255T3 DK 0542255 T3 DK0542255 T3 DK 0542255T3 DK 92119353 T DK92119353 T DK 92119353T DK 92119353 T DK92119353 T DK 92119353T DK 0542255 T3 DK0542255 T3 DK 0542255T3
Authority
DK
Denmark
Prior art keywords
hbnp
monoclonal antibody
terminus
antibody recognizing
immunoassay
Prior art date
Application number
DK92119353T
Other languages
Danish (da)
English (en)
Inventor
Masao Kono
Akira Yamauchi
Tetsuo Tsuji
Ken Inouye
Ken Ichi Igano
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0542255T3 publication Critical patent/DK0542255T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
DK92119353T 1991-11-14 1992-11-12 Monoklont antistof, der genkender C-terminus i hBNP DK0542255T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3326961A JP2665850B2 (ja) 1991-11-14 1991-11-14 ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体

Publications (1)

Publication Number Publication Date
DK0542255T3 true DK0542255T3 (da) 1999-05-10

Family

ID=18193724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92119353T DK0542255T3 (da) 1991-11-14 1992-11-12 Monoklont antistof, der genkender C-terminus i hBNP

Country Status (10)

Country Link
US (2) US6677124B2 (zh)
EP (1) EP0542255B1 (zh)
JP (1) JP2665850B2 (zh)
KR (1) KR100248315B1 (zh)
AT (1) ATE176804T1 (zh)
DE (1) DE69228436T2 (zh)
DK (1) DK0542255T3 (zh)
ES (1) ES2129421T3 (zh)
GR (1) GR3029904T3 (zh)
TW (1) TW230787B (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2665850B2 (ja) * 1991-11-14 1997-10-22 塩野義製薬株式会社 ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
PT2292662E (pt) 1996-03-04 2014-07-16 Scios Inc Ensaio e reagentes para a quantificação de hbnp
US6117644A (en) * 1998-06-04 2000-09-12 Ottawa Heart Institute Research Corporation Predicting and detecting cardiac allograft rejection
US7432060B2 (en) 2000-11-09 2008-10-07 The Brigham And Women's Hospital, Inc. Methods for diagnosis of cardiovascular disease
US20040253242A1 (en) * 2000-12-05 2004-12-16 Bowdish Katherine S. Rationally designed antibodies
ATE414720T1 (de) 2000-12-05 2008-12-15 Alexion Pharma Inc Rationell entworfene antikörper
US7396917B2 (en) 2000-12-05 2008-07-08 Alexion Pharmaceuticals, Inc. Rationally designed antibodies
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US7524635B2 (en) 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
HUE039881T2 (hu) 2002-05-09 2019-02-28 Brigham & Womens Hospital Inc 1L1RL-1, mint egy kardiovaszkuláris betegség-marker
JP4496407B2 (ja) 2002-05-13 2010-07-07 ベクトン・ディキンソン・アンド・カンパニー プロテアーゼ阻害剤試料採取システム
US8263325B2 (en) 2002-11-15 2012-09-11 Ottawa Heart Institute Research Corporation Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis
CN100558398C (zh) 2002-11-26 2009-11-11 拜奥康有限公司 修饰的钠尿化合物、缀合物及其应用
US7648962B2 (en) * 2002-11-26 2010-01-19 Biocon Limited Natriuretic compounds, conjugates, and uses thereof
US7476363B2 (en) * 2003-04-03 2009-01-13 Fluidigm Corporation Microfluidic devices and methods of using same
EP2949669A1 (en) 2003-05-12 2015-12-02 Roche Diagnostics GmbH Method of detecting native probnp
GB2403533A (en) 2003-06-30 2005-01-05 Orion Corp Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
WO2006076471A2 (en) * 2005-01-12 2006-07-20 Nobex Corporation Bnp conjugates and methods of use
US7731965B2 (en) * 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
US20070207152A1 (en) * 2005-11-09 2007-09-06 Brophy Susan E Human BNP immunospecific antibodies
US7939069B2 (en) 2005-11-09 2011-05-10 Abbott Laboratories Human BNP immunospecific antibodies
ES2378314T3 (es) 2006-04-24 2012-04-11 Critical Care Diagnostics, Inc. Predicción de la mortalidad y detección de enfermedades graves.
WO2007130962A2 (en) * 2006-05-01 2007-11-15 Critical Care Diagnostics, Inc. Diagnosis of cardiovascular disease
US20080064045A1 (en) 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP
JP5570415B2 (ja) * 2007-05-08 2014-08-13 アボット・ラボラトリーズ 他のペプチド型に対する交差反応性の低いヒトｂ型ナトリウム利尿ペプチドアッセイ
US20090203038A1 (en) * 2007-12-27 2009-08-13 Abbott Laboratories Negative Mimic Antibody For Use as a Blocking Reagent In BNP Immunoassays
PL2827152T3 (pl) 2008-04-18 2016-12-30 Rokowanie ryzyka głównych niekorzystnych zdarzeń sercowych
US20090286256A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratories Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
US20090286329A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratoires Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
JP5810514B2 (ja) * 2009-12-07 2015-11-11 東ソー株式会社 タグペプチド
CN111834009A (zh) 2012-08-21 2020-10-27 重症监护诊断股份有限公司 多标记风险分层
CN103869085A (zh) * 2014-04-04 2014-06-18 郑州安图生物工程股份有限公司 一种检测人源n端-b型钠尿肽前体的试剂盒
CN104880446B (zh) * 2015-06-01 2018-11-20 上海凯创生物技术有限公司 一种脑钠肽近红外荧光检测试剂盒及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271140A (en) * 1978-01-23 1981-06-02 Baxter Travenol Laboratories, Inc. Method and composition for double receptor, specific binding assays
DE3509958A1 (de) * 1985-03-20 1986-09-25 Bayer Ag, 5090 Leverkusen Monoklonale antikoerper gegen atriale, natriuretische peptide vom menschen
CA1335082C (en) 1987-09-01 1995-04-04 Hiroo Imura Monoclonal antibody recognizing –-hanp and a reagent for immunoassay of –-hanp
JP2665850B2 (ja) * 1991-11-14 1997-10-22 塩野義製薬株式会社 ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
PT2292662E (pt) * 1996-03-04 2014-07-16 Scios Inc Ensaio e reagentes para a quantificação de hbnp

Also Published As

Publication number Publication date
ATE176804T1 (de) 1999-03-15
ES2129421T3 (es) 1999-06-16
GR3029904T3 (en) 1999-07-30
KR930010191A (ko) 1993-06-22
EP0542255A1 (en) 1993-05-19
DE69228436D1 (de) 1999-03-25
TW230787B (zh) 1994-09-21
US20040253655A1 (en) 2004-12-16
JPH05184384A (ja) 1993-07-27
KR100248315B1 (ko) 2000-03-15
US20020025559A1 (en) 2002-02-28
JP2665850B2 (ja) 1997-10-22
DE69228436T2 (de) 1999-07-22
EP0542255B1 (en) 1999-02-17
US6677124B2 (en) 2004-01-13

Similar Documents

Publication Publication Date Title
DK0542255T3 (da) Monoklont antistof, der genkender C-terminus i hBNP
ES2094733T3 (es) Deteccion de enfermedades o disfunciones neurologicas.
ATE114672T1 (de) Peptidzusammensetzung und verfahren zum nachweis von antikörpern gegen htlv-iii.
FI20030652A0 (fi) Parannettu immunomääritys
ES2161751T3 (es) Anticuerpo monoclonal que se une especificamente al endotelio vascular tumoral y usos del mismo.
DE69633973D1 (de) Antikörper gegen die alpha-kette von humanem interleukin 5 rezeptor
ATE154642T1 (de) Monoklonale antikörper gegen das mikrotubulusassoziierte protein tau.
ATE180511T1 (de) Humanisierter b-b10, ein anti-il-2-rezeptor- antikörper
DK0625912T3 (da) Behandling af inflammatorisk tarmsygdom
EP0674661A4 (en) TITRATION AND TREATMENT FOR DEMYELINIZING DISEASES SUCH AS MULTIPLE SCLEROSIS.
FR2637600B1 (fr) Peptides et polypeptides provenant de la glande sous maxillaire du rat, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et applications de ces produits au diagnostic, a la detection ou a des fins therapeutiques
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
DE69221104T2 (de) Immunoassay für NCA-BT in Blutproben von Brustkrebspatientinnen
DE69123724D1 (de) Verfahren zur diagnose von hiv-infektionen
EP0907080B1 (en) Method for assaying antigen relating to mental stress disorders
ATE86261T1 (de) Tumorassoziiertes antigen.
ATE231167T1 (de) Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper
EP0602248A4 (en) Monoclonal antibody against human lung surfactant apoprotein d and use thereof.